Dexcom (DXCM) Shares Outstanding (2010 - 2026)

Dexcom (DXCM) has 17 years of Shares Outstanding (Entity) data on file, last reported at $412.3 million in Q1 2026.

• On a quarterly basis, Shares Outstanding (Entity) changed 0.49% year-over-year to $412.3 million in Q1 2026; TTM through Mar 2026 was $412.3 million, a 0.49% change from a year earlier, with the FY2025 full-year figure at $410.7 million, changed 0.44% from the prior year.
• Shares Outstanding (Entity) for Q1 2026 stood at $412.3 million, roughly flat from $410.7 million in the prior quarter.
• Over the last five years, Shares Outstanding (Entity) for DXCM reached as high as $412.3 million in Q1 2026 and fell as low as $392.8 million in Q1 2022.
• Historically, Shares Outstanding (Entity) has averaged $403.7 million across 5 years, with a median of $408.5 million in 2024.
• Across the five-year window, Shares Outstanding (Entity) gained 3.56% in 2023 and advanced 0.42% in 2024, its largest moves.
• Year by year, Shares Outstanding (Entity) stood at $393.2 million in 2022, then advanced by 3.56% to $407.2 million in 2023, then grew by 0.42% to $408.9 million in 2024, then gained by 0.44% to $410.7 million in 2025, then grew by 0.39% to $412.3 million in 2026.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $412.3 million in Q1 2026, $410.7 million in Q4 2025, and $410.6 million in Q3 2025.